Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)
Landgren, C. Ola, Chari, Ajai, Cohen, Yael C., Spencer, Andrew, Voorhees, Peter, Estell, Jane A., Sandhu, Irwindeep, Jenner, Matthew W., Williams, Catherine, Cavo, Michele, van de Donk, Niels W. C. J., Beksac, Meral, Moreau, Philippe, Goldschmidt, Hartmut, Kuppens, Steven, Bandekar, Rajesh, Clemens, Pamela L., Neff, Tobias, Heuck, Christoph, Qi, Ming, Hofmeister, Craig C.
Published in Leukemia (01.07.2020)
Published in Leukemia (01.07.2020)
Get full text
Journal Article
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
van Rhee, Frits, Prof, Wong, Raymond S, Prof, Munshi, Nikhil, Prof, Rossi, Jean-Francois, Prof, Ke, Xiao-Yan, Prof, Fosså, Alexander, MD, Simpson, David, MD, Capra, Marcelo, MD, Liu, Ting, MD, Hsieh, Ruey Kuen, MD, Goh, Yeow Tee, MD, Zhu, Jun, MD, Cho, Seok-Goo, MD, Ren, Hanyun, MD, Cavet, James, MD, Bandekar, Rajesh, PhD, Rothman, Margaret, PhD, Puchalski, Thomas A, PharmD, Reddy, Manjula, MSc, van de Velde, Helgi, MD, Vermeulen, Jessica, MD, Casper, Corey, Prof
Published in The lancet oncology (01.08.2014)
Published in The lancet oncology (01.08.2014)
Get full text
Journal Article
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer with and without Prior Abiraterone Acetate and Prednisone
Rathkopf, Dana E, Antonarakis, Emmanuel S, Shore, Neal D, Tutrone, Ronald F, Alumkal, Joshi J, Ryan, Charles J, Saleh, Mansoor, Hauke, Ralph J, Bandekar, Rajesh, Maneval, Edna Chow, de Boer, Carla J, Yu, Margaret K, Scher, Howard I
Published in Clinical cancer research (15.07.2017)
Published in Clinical cancer research (15.07.2017)
Get full text
Journal Article
Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort
Smith, Matthew R, Antonarakis, Emmanuel S, Ryan, Charles J, Berry, William R, Shore, Neal D, Liu, Glenn, Alumkal, Joshi J, Higano, Celestia S, Chow Maneval, Edna, Bandekar, Rajesh, de Boer, Carla J, Yu, Margaret K, Rathkopf, Dana E
Published in European urology (01.12.2016)
Published in European urology (01.12.2016)
Get full text
Journal Article
Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Brighton, Timothy A, Khot, Amit, Harrison, Simon J, Ghez, David, Weiss, Brendan M, Kirsch, Andres, Magen, Hila, Gironella, Mercedes, Oriol, Albert, Streetly, Matthew, Kranenburg, Britte, Qin, Xiang, Bandekar, Rajesh, Hu, Peter, Guilfoyle, Mary, Qi, Ming, Nemat, Sepideh, Goldschmidt, Hartmut
Published in Clinical cancer research (01.07.2019)
Published in Clinical cancer research (01.07.2019)
Get full text
Journal Article
Phase 2 trial results with the novel neurokinin‐1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy‐induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Arpornwirat, Wichit, Albert, Istvan, Hansen, Vincent L., Levin, Jeremey, Bandekar, Rajesh R., Grunberg, Steven M.
Published in Cancer (15.12.2009)
Published in Cancer (15.12.2009)
Get full text
Journal Article
Bone Mineral Density and Its Change in Pre‐ and Perimenopausal White Women: The Michigan Bone Health Study
Sowers, Maryfran, Crutchfield, Mary, Bandekar, Rajesh, Randolph, John F., Shapiro, Brahm, Schork, M. Anthony, Jannausch, Mary
Published in Journal of bone and mineral research (01.07.1998)
Published in Journal of bone and mineral research (01.07.1998)
Get full text
Journal Article
Cost-effectiveness comparison of therapy for psoriasis with a methotrexate-based regimen versus a rotation regimen of modified cyclosporine and methotrexate
Ellis, Charles N., Reiter, Kristin L., Bandekar, Rajesh R., Fendrick, A.Mark
Published in Journal of the American Academy of Dermatology (01.02.2002)
Published in Journal of the American Academy of Dermatology (01.02.2002)
Get full text
Journal Article
Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease
Casper, Corey, Chaturvedi, Shalini, Munshi, Nikhil, Wong, Raymond, Qi, Ming, Schaffer, Michael, Bandekar, Rajesh, Hall, Brett, van de Velde, Helgi, Vermeulen, Jessica, Reddy, Manjula, van Rhee, Frits
Published in Clinical cancer research (01.10.2015)
Published in Clinical cancer research (01.10.2015)
Get full text
Journal Article
A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
ANGEVIN, Eric, TABERNERO, Josep, RAY-COQUARD, Isabelle, DIRIX, Luc, MACHIELS, Jean-Pascal, STEVEN, Neil, REDDY, Manjula, HALL, Brett, PUCHALSKI, Thomas A, BANDEKAR, Rajesh, VAN DE VELDE, Helgi, TROMP, Brenda, ELEZ, Elena, VERMEULEN, Jessica, KURZROCK, Razelle, COHEN, Steven J, BAHLEDA, Rastilav, VAN LAETHEM, Jean-Luc, OTTENSMEIER, Christian, LOPEZ-MARTIN, Jose A, CLIVE, Sally, JOLY, Florence
Published in Clinical cancer research (15.04.2014)
Published in Clinical cancer research (15.04.2014)
Get full text
Journal Article
A phase 2, randomized, double‐blind, placebo‐controlled study of siltuximab (anti‐IL‐6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
Orlowski, Robert Z., Gercheva, Liana, Williams, Cathy, Sutherland, Heather, Robak, Tadeusz, Masszi, Tamás, Goranova‐Marinova, Vesselina, Dimopoulos, Meletios A., Cavenagh, James D., Špička, Ivan, Maiolino, Angelo, Suvorov, Alexander, Bladé, Joan, Samoylova, Olga, Puchalski, Thomas A., Reddy, Manjula, Bandekar, Rajesh, van de Velde, Helgi, Xie, Hong, Rossi, Jean‐Franςois
Published in American journal of hematology (01.01.2015)
Published in American journal of hematology (01.01.2015)
Get full text
Journal Article
Randomized, open-label, phase 3 study of subcutaneous daratumumab (DARA SC) versus active monitoring in patients (Pts) with high-risk smoldering multiple myeloma (SMM): AQUILA
Rajkumar, S.Vincent, Voorhees, Peter Michael, Goldschmidt, Hartmut, Baker, Ross I., Bandekar, Rajesh, Kuppens, Steven, Neff, Tobias, Qi, Ming, Dimopoulos, Meletios A.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma
Brighton, Timothy, Harrison, Simon J., Ghez, David, Weiss, Brendan M., Kirsch, Andreas, Magen, Hila, Gironella, Mercedes, Oriol, Albert, Streetly, Matthew, Qin, Xiang, Bandekar, Rajesh, Hu, Peter, Qi, Ming, Nemat, Sepideh, Goldschmidt, Hartmut
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Updated Results from the Phase 2 Centaurus Study of Daratumumab (DARA) Monotherapy in Patients with Intermediate-Risk or High-Risk Smoldering Multiple Myeloma (SMM)
Landgren, Ola, Cavo, Michele, Chari, Ajai, Cohen, Yael C, Spencer, Andrew, Voorhees, Peter M., Estell, Jane, Sandhu, Irwindeep, Jenner, Matthew, Williams, Catherine, van de Donk, Niels WCJ, Beksac, Meral, Goldschmidt, Hartmut, Moreau, Philippe, Kuppens, Steven, Bandekar, Rajesh, Neff, Tobias, Cortoos, Annelore, Clemens, Pamela L, Qi, Ming, Adams, Homer, Hofmeister, Craig C
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy
Chari, Ajai, Munder, Markus, Weisel, Katja, Jenner, Matthew, Bygrave, Ceri, Petrucci, Maria Teresa, Boccadoro, Mario, Cavo, Michele, van de Donk, Niels W. C. J., Turgut, Mehmet, Demirkan, Fatih, Karadogan, Ihsan, Libby, Edward, Kleiman, Robert, Kuppens, Steven, Bandekar, Rajesh, Neff, Tobias, Heuck, Christoph, Qi, Ming, Clemens, Pamela L., Goldschmidt, Hartmut
Published in Advances in therapy (01.02.2021)
Published in Advances in therapy (01.02.2021)
Get full text
Journal Article
Safety and Antitumor Activity of Apalutamide (ARN-509) in Metastatic Castration-Resistant Prostate Cancer Patients with and without Prior Abiraterone Acetate and Prednisone
Rathkopf, Dana E., Antonarakis, Emmanuel S., Shore, Neal D., Tutrone, Ronald F., Alumkal, Joshi J., Ryan, Charles J., Saleh, Mansoor, Hauke, Ralph J., Bandekar, Rajesh, Maneval, Edna Chow, de Boer, Carla J., Yu, Margaret K., Scher, Howard I.
Published in Clinical cancer research (17.02.2017)
Published in Clinical cancer research (17.02.2017)
Get full text
Journal Article